|
| 37990759 | Uncovering prostate cancer aggressiveness signal in T2-weighted MRI through a three-reference tissues normalization technique. | NMR Biomed | 2024 |
| 36596346 | Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International Consensus. | Int J Radiat Oncol Biol Phys | 2023 |
| 37808453 | ESTRO ACROP consensus recommendation on the target volume definition for radiation therapy of macroscopic prostate cancer recurrences after radical prostatectomy. | Clin Transl Radiat Oncol | 2023 |
| 37525535 | Use of the Decipher genomic classifier among men with prostate cancer in the United States. | JNCI Cancer Spectr | 2023 |
| 37487297 | Bone marrow sparing in prostate cancer patients treated with Post-operative pelvic nodal radiotherapy - A proton versus photon comparison. | Phys Med | 2023 |
| 38033493 | Predicting response to immunotherapy in non-small cell lung cancer- from bench to bedside. | Front Oncol | 2023 |
| 37251620 | ESTROÂ ACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer. | Clin Transl Radiat Oncol | 2023 |
| 37366877 | Multi-Institutional Patterns of Use of Tumor-Treating Fields for Patients with Malignant Pleural Mesothelioma. | Curr Oncol | 2023 |
| 37270247 | Passing the Kool-Aid Point: mRNA Expression-Based Risk Classifiers in Localized Prostate Cancer Treatment Decision Making. | Int J Radiat Oncol Biol Phys | 2023 |
| 36522269 | Distinct Profiles of DNA Repair Activity Define Favorable-risk Prostate Cancer Subtypes With Divergent Outcome. | Clin Genitourin Cancer | 2023 |
| 36759200 | [68]Ga-PSMA PET/CT-Based Atlas for Prostate Bed Recurrence After Radical Prostatectomy: Clinical Implications for Salvage Radiation Therapy Contouring Guidelines. | J Nucl Med | 2023 |
| 35022600 | Clinicogenomic characterization of prostate cancer liver metastases. | Prostate Cancer Prostatic Dis | 2022 |
| 35671868 | Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer. | Int J Radiat Oncol Biol Phys | 2022 |
| 35636621 | Validation of the Decipher genomic classifier in patients receiving salvage radiotherapy without hormone therapy after radical prostatectomy - an ancillary study of the SAKK 09/10 randomized clinical trial. | Ann Oncol | 2022 |
| 36418901 | Cone-beam CT delta-radiomics to predict genitourinary toxicities and international prostate symptom of prostate cancer patients: a pilot study. | Sci Rep | 2022 |
| 35936742 | Erring Characteristics of Deformable Image Registration-Based Auto-Propagation for Internal Target Volume in Radiotherapy of Locally Advanced Non-Small Cell Lung Cancer. | Front Oncol | 2022 |
| 36175971 | Assessment of IMPT versus VMAT plans using different uncertainty scenarios for prostate cancer. | Radiat Oncol | 2022 |
| 36139635 | Longitudinal Changes and Predictive Value of Multiparametric MRI Features for Prostate Cancer Patients Treated with MRI-Guided Lattice Extreme Ablative Dose (LEAD) Boost Radiotherapy. | Cancers (Basel) | 2022 |
| 36383304 | Stereotactic Body Radiotherapy for Localized Kidney Cancer. | Curr Urol Rep | 2022 |
| 36228761 | Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus. | Radiother Oncol | 2022 |
| 33356482 | Heterogeneity in Genomic Risk Assessment from Tissue Based Prognostic Signatures Used in the Biopsy Setting and the Impact of Magnetic Resonance Imaging Targeted Biopsy. | J Urol | 2021 |
| 33598943 | Repeatability of CBCT radiomic features and their correlation with CT radiomic features for prostate cancer. | Med Phys | 2021 |
| 34869943 | Levels of Evidence for Radiation Therapy Recommendations in the National Comprehensive Cancer Network (NCCN) Clinical Guidelines. | Adv Radiat Oncol | 2021 |
| 34551377 | Novel genomic signature predictive of response to immune checkpoint blockade: A pan-cancer analysis from project Genomics Evidence Neo-plasia Information Exchange (GENIE). | Cancer Genet | 2021 |
| 34666186 | The Impact of Pelvic Nodal Radiotherapy on Hematologic Toxicity: A Systematic Review with Focus on Leukopenia, Lymphopenia and Future Perspectives in Prostate Cancer Treatment. | Crit Rev Oncol Hematol | 2021 |
| 34722812 | Assessment of Knowledge-Based Planning for Prostate Intensity Modulated Proton Therapy. | Int J Part Ther | 2021 |
| 33445124 | Assessment of daily dose accumulation for robustly optimized intensity modulated proton therapy treatment of prostate cancer. | Phys Med | 2021 |
| 32221622 | Segmentation of prostate and prostate zones using deep learning : AÂ multi-MRI vendor analysis. | Strahlenther Onkol | 2020 |
| 32014149 | Shifting the Curtain-Can We Make Sense of the Whole Pelvis Controversy? | Int J Radiat Oncol Biol Phys | 2020 |
| 33312960 | Radiation-Induced Lymphopenia Beyond the COVID-19 Pandemic. | Front Oncol | 2020 |
| 32862068 | Margin verification for hypofractionated prostate radiotherapy using a novel dose accumulation workflow and iterative CBCT. | Phys Med | 2020 |
| 32821953 | The role of radiomics in prostate cancer radiotherapy. | Strahlenther Onkol | 2020 |
| 32956564 | Impacts of post-radiotherapy lymphocyte count on progression-free and overall survival in patients with stage III lung cancer. | Thorac Cancer | 2020 |
| 32783629 | Toxicity reduction required for MRI-guided radiotherapy to be cost-effective in the treatment of localized prostate cancer. | Br J Radiol | 2020 |
| 33008661 | Re: Carlo A. Bravi, Nicoal Fossati, Giorgio Gandaglia, et al. Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought. Eur Urol 2020;78:661-9. | Eur Urol | 2020 |
| 32424273 | Using hormone therapy with salvage radiotherapy according to presalvage PSA levels. | Nat Rev Urol | 2020 |
| 30553614 | Local Treatment in Metastatic Prostate Cancer: A Cultural Shift Confronts Power and Selection. | Eur Urol | 2019 |
| 31300233 | Re: Gaëtan Devos, Gert De Meerleer, Steven Joniau. Have We Entered the Era of Imaging Before Salvage Treatment for Recurrent Prostate Cancer? Eur Urol 2019;76:265-7. | Eur Urol | 2019 |
| 31619296 | Radiotherapy for pelvic nodal recurrences after radical prostatectomy: patient selection in clinical practice. | Radiat Oncol | 2019 |
| 30873377 | Disease Control With Delayed Salvage Radiotherapy for Macroscopic Local Recurrence Following Radical Prostatectomy. | Front Oncol | 2019 |
| 28890243 | Re: Giorgio Gandaglia, Stephen A. Boorjian, William P. Parker, et al. Impact of Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis. Eur Urol 2017;72:910-7. | Eur Urol | 2018 |
| 30103771 | Protocol for serum exosomal miRNAs analysis in prostate cancer patients treated with radiotherapy. | J Transl Med | 2018 |
| 30050803 | Magnetic resonance imaging (MRI)-based radiomics for prostate cancer radiotherapy. | Transl Androl Urol | 2018 |
| 30050800 | Contemporary role of postoperative radiotherapy for prostate cancer. | Transl Androl Urol | 2018 |
| 29908220 | An Automated Multiparametric MRI Quantitative Imaging Prostate Habitat Risk Scoring System for Defining External Beam Radiation Therapy Boost Volumes. | Int J Radiat Oncol Biol Phys | 2018 |
| 30400969 | Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation. | Radiat Oncol | 2018 |
| 29103826 | Impact of dose intensified salvage radiation therapy on urinary continence recovery after radical prostatectomy: Results of the randomized trial SAKK 09/10. | Radiother Oncol | 2018 |
| 28656373 | Salvage radiotherapy for macroscopic local recurrences after radical prostatectomy : AÂ national survey on patterns of practice. | Strahlenther Onkol | 2018 |
| 28068672 | Genomic hallmarks of localized, non-indolent prostate cancer. | Nature | 2017 |
| 28474090 | T1-2 glottic cancer treated with radiotherapy and/or surgery. | Strahlenther Onkol | 2017 |